Type 1 diabetes is a lifelong disease that affects the body’s ability to convert glucose from food into energy. In most cases, type 1 diabetes develops early in life and is often diagnosed during childhood.
The disease starts when the immune system attacks cells in the pancreas that produce insulin, the hormone that helps convert glucose into energy for the body’s cells. Without daily injections of insulin, people living with type 1 would not be able to survive.
Based on almost 100 years of experience discovering and producing treatments for people with diabetes, our scientists are advancing research to reduce the number of insulin injections required to maintain good glycaemic control, and to prevent low blood glucose (hypoglycaemic) episodes.
Our ultimate goal is a cure for type 1 diabetes. We are progressing our research in regenerative medicine such as stem cell therapy, which may one day be used as a curative treatment of type 1 diabetes.
Meet Nic, who has type 1 diabetes, and hear about life with the disease.
Meet Jacob Sten Petersen, Head of Stem Cell research, and hear his personal motivation to find a cure for type 1 diabetes.
Johnna Wesley, head of type 1 diabetes, immunology and kidney disease research